Document is current

Any future updates will be listed below

Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent

Crossref DOI link: https://doi.org/10.1186/s12967-014-0356-1

Published Online: 2014-12-19

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark